NANO BABO LIMITED

11937660
Dissolved Harrow

Management consultancy activities other than financial management

0 employees website.com
Management consultancy activities other than financial management
N

NANO BABO LIMITED

11937660

Management consultancy activities other than financial management

Founded 10 Apr 2019 Dissolved Harrow, England 0 employees website.com
Management consultancy activities other than financial management

Previous Company Names

ECOMPLIANCEPLUS LIMITED 10 Apr 2019 — 13 Jul 2020
Accounts Submitted 29 Apr 2023
Confirmation Submitted 17 Nov 2022 Next due 24 Sept 2023 34 months overdue
Net assets £-37K £23K 2022 year on year
Total assets £13K £12K 2022 year on year
Total Liabilities £50K £36K 2022 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

140a Station Road Harrow HA1 2RH England

Full company profile for NANO BABO LIMITED (11937660), a dissolved company based in Harrow, England. Incorporated 10 Apr 2019. Management consultancy activities other than financial management. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2022
Type unaudited-abridged
Next accounts
Due by

Net Assets, Total Assets & Total Liabilities (2020–2022)

Cash in Bank

£1.89k

Increased by £1.37k (+263%)

Net Assets

-£37.05k

Decreased by £23.40k (-171%)

Total Liabilities

£49.74k

Increased by £35.57k (+251%)

Turnover

N/A

Employees

N/A

Debt Ratio

392%

Decreased by 2333 (-86%)

Financial History

Revenue, profit, EBITDA and key financial figures

2022
30 Apr Year End
2021
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Mitul Nemchand ShahDirectorBritishEngland443 Jul 2019Active

Shareholders

Shareholders (2)

Isome Limited
100.0%
100
Nami Pharmaceuticals
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Mitul Nemchand Shah

British

Active
Notified 5 Jul 2020
Residence England
DOB December 1981
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Nami Pharmaceuticals

Ceased 4 Jul 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Jul 2023GazetteGazette Dissolved Voluntary
29 Apr 2023AccountsAnnual accounts made up to 30 Apr 2022
25 Apr 2023GazetteGazette Notice Voluntary
18 Apr 2023DissolutionDissolution Application Strike Off Company
17 Nov 2022Confirmation StatementConfirmation statement made on 10 Sept 2022 with no updates
11 Jul 2023 Gazette

Gazette Dissolved Voluntary

29 Apr 2023 Accounts

Annual accounts made up to 30 Apr 2022

25 Apr 2023 Gazette

Gazette Notice Voluntary

18 Apr 2023 Dissolution

Dissolution Application Strike Off Company

17 Nov 2022 Confirmation Statement

Confirmation statement made on 10 Sept 2022 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

2 years ago on 11 Jul 2023

Annual accounts made up to 30 Apr 2022

3 years ago on 29 Apr 2023

Gazette Notice Voluntary

3 years ago on 25 Apr 2023

Dissolution Application Strike Off Company

3 years ago on 18 Apr 2023

Confirmation statement made on 10 Sept 2022 with no updates

3 years ago on 17 Nov 2022